Vascular Magnetics
Operating Status: Closed
Vascular Magnetics, Inc. develops targeted, magnetic therapeutics for peripheral artery disease treatment.
Founded
2010Vascular Magnetics, Inc. develops targeted, magnetic therapeutics for peripheral artery disease treatment.
Vascular Magnetics, Inc. was founded with the mission to revolutionize the treatment of peripheral artery disease (PAD) through innovative therapeutic solutions. The company's core vision is to enhance patient outcomes by developing targeted, magnetic therapeutics that deliver drug-loaded biodegradable particles directly to affected areas. Vascular Magnetics focuses on providing these advanced therapies to vascular surgeons and surgical centers across the United States.
Notable figures affiliated with Vascular Magnetics include leading experts in vascular surgery and biomedical engineering, who contribute to the company's pioneering research and development efforts. The company has garnered significant attention from investors interested in cutting-edge medical technologies. Vascular Magnetics' key achievements include the successful development and initial market introduction of its magnetic vascular intervention therapy, which has shown promising results in clinical settings, thereby making a substantial impact on the treatment landscape for PAD.
Companies similar to Vascular Magnetics include TheraVasc, Euphrates Vascular, R3 Vascular and Vascular Imaging.
Vascular Magnetics was founded in 2010.
Vascular Magnetics' headquarters is located in Philadelphia, PA, US.
Vascular Magnetics' most recent funding round was for $7M (USD) in February 2012.
As of Feb 22, 2012, Vascular Magnetics has disclosed funding of $7M (USD). Undisclosed round amounts are excluded.
Vascular Imaging
